GenrAb

Manufacturing · Texas, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1401 Hawthorn Way, Westlake, Texas, 7626...

Phone Number

(858) 245-8489

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About GenrAb

GenrAb is focused on developing neuroprotective therapies that harness the power of human immunity to protect and treat patients with neurological diseases. They utilize their proprietary Antibody Gene Signature technology to identify potentially therapeutic fully-human monoclonal antibodies. Their lead candidate, TGM-010, shows promise in preventing disease progression and enhancing patient care across multiple neurodegenerative disorders. GenrAb aims not only to advance scientific understanding but also to profoundly impact the lives of patients by transforming neurological care.Explore more
Popular SearchesGenrAbGenrab IncSIC Code 28,283NAICS Code 32,325Show more

GenrAb Org Chart

PhoneEmail
TM
United States flag for contact location.

Senior Research Associate

PhoneEmail
JH
United States flag for contact location.

Senior Scientist

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is GenrAb your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to GenrAb

Compare insights from companies similar to GenrAb, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

GenrAb

<$5M
11-50
Private
$5.6M
-
TM
Touhidul MollaSenior Research Associate
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
2021
<$5M
11-50
Private
-
-
DC
David ColaizziCEO & Co-Founder
<$5M
11-50
Private
$60.8M
2022
MC
Marco CrosariolVice Head of Operations, President
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

GenrAb is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

GenrAb is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GenrAb.

GenrAb financials insights

Gather financial insights about GenrAb, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2025

Angel/Seed

$5.6M

See All GenrAb's Financials Insights

GenrAb Tech Stack

A closer look at the technologies used by GenrAb

GenrAb News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding GenrAb

What is GenrAb's official website?
GenrAb's official website is www.genrab.com
What is GenrAb's Revenue?
GenrAb's revenue is <$5 Million
What is GenrAb's SIC code?
GenrAb's SIC: 28,283
What is GenrAb's NAICS code?
GenrAb's NAICS: 32,325
How many employees does GenrAb have?
GenrAb has 11-50 employees
What industry does GenrAb belong to?
GenrAb is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is GenrAb competition?
GenrAb top competitors include: Neuroboxing, SonoThera, Steritas, SignatureDx
What technology does GenrAb use?
Some of the popular technologies that GenrAb uses are: WordPress.org, PHP, Google Font API, MediaElement.js
How do I contact GenrAb?
GenrAb contact info: Phone number: (858) 245-8489 Website: www.genrab.com
What does GenrAb do?

GenrAb is focused on developing neuroprotective therapies that harness the power of human immunity to protect and treat patients with neurological diseases. They utilize their proprietary Antibody Gene Signature technology to identify potentially therapeutic fully-human monoclonal antibodies. Their lead candidate, TGM-010, shows promise in preventi... ng disease progression and enhancing patient care across multiple neurodegenerative disorders. GenrAb aims not only to advance scientific understanding but also to profoundly impact the lives of patients by transforming neurological care.Read More

Is GenrAb a public company?
GenrAb is private company therefore does not currently have an official ticker symbol
See more information about GenrAb

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.